Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Method of inhibiting glycolipid synthesis|
|Abstract:||A method is disclosed for inhibiting the biosynthesis of glycolipids in cells capable of producing glycolipids comprising subjecting said cells to a glycolipid inhibitory effective amount of an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol in which said alkyl contains from 2-8 carbon atoms.|
|Inventor(s):||Platt; Frances M. (Oxford, GB), Neises; Gabrielle R. (Chesterfield, MO), Dwek; Raymond A. (Oxford, GB), Butters; Terry D. (Oxford, GB)|
|Assignee:||Monsanto Company (St. Louis, MO)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Publication Date|
|World Intellectual Property Organization (WIPO)||9830219||Jul 16, 1998|
|World Intellectual Property Organization (WIPO)||9426714||Nov 24, 1994|
|United States of America||6291657||Sep 18, 2001|
|United States of America||5801185||Sep 01, 1998|
|United States of America||5798366||Aug 25, 1998|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.